A series of papers in The Lancet highlights how city planning and urban design can prevent chronic diseases and create healthier and more sustainable cities.
By 2050, 75% of the world’s population is expected to live in cities, making city planning key for addressing disease prevention and global health challenges, according to a series published in The Lancet. City planning that encourages walking, cycling, and public transportation can directly and indirectly affect non-communicable diseases, such as cardiovascular disease and diabetes, traffic injuries, and other adverse health and environmental outcomes.
The series was led by the University of Melbourne in Australia and the University of California, San Diego. The series’ authors identified key regional planning and local urban design interventions needed to create cities that promote health. The 3 interventions part of regional planning are destination accessibility, distribution of employment, demand management. The 5 interventions part of local urban design are design, density, distance to public transport, diversity, and desirability.
“With the world’s population estimated to reach 10 billion people by 2050, and three quarters of this population living in cities, city planning must be part of a comprehensive solution to tackling adverse health outcomes,” series author Professor Billie Giles-Corti, University of Melbourne, Australia, said in a statement. “City planning was key to cutting infectious disease outbreaks in the 19th century through improved sanitation, housing and separating residential and industrial areas. Today, there is a real opportunity for city planning to reduce non-communicable diseases and road trauma and to promote health and wellbeing more broadly.”
Giles-Corti added that the researchers had concluded that focusing on walking and cycling alone was not enough. Cities needed policies that included input from multiple sectors: land use, transport, housing, economic development, urban design, health and community services, and public safety.
In one paper of the series, researchers used a health impact assessment framework to estimate the population health effects arising from alternative land-use and transport policy initiatives in Melbourne, London, Boston, Sao Paulo, Copenhagen, and Dehli. As part of the model, land-use density was increased by 30%, which reduced the average distance to public transportation by 30%, and the diversity of land-use was also increased by 30%. Assuming a 10% shift from private cars to either cycling or walking, the researchers predicted health gains in all cities.
“Many countries concerned by the costs associated with the mounting burden of lifestyle-related chronic disease have put in place plans and public policy initiatives that encourage increased levels of physical activity,” the authors wrote. Although the successful implementation of these plans varies, the study’s findings “suggest that government policies need to actively pursue integrated urban and transport planning and design interventions—particularly those focused towards achieving more compact cities—that support and encourage model shifts away from private motor vehicles towards new urban mobility.”
In a commentary, New York City Mayor Bill de Blasio wrote on the importance of parks and green space in urban areas. New York City has nearly 30,000 acres of beaches, community gardens, playing fields, hiking trails and more. A new initiative in New York is adopting strategies to ensure everyone can use these green spaces.
“Today, the City of New York is using the power of green spaces to strengthen the overall health of our thriving metropolis, especially in low-income neighborhoods that are grappling with health disparities,” de Blasio wrote.
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers
November 13th 2024Employees living with diabetes often face unique challenges, such as managing blood sugar levels, balancing medication, and preventing complications, all while maintaining their professional responsibilities. This condition can lead to increased absenteeism, reduced productivity, and rising health care costs.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen